dsip 구매 상품상세 대체 품목 구매 시 빠른

Low doses of 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, stimulate angiogenesis by regulating expression of urokinase type plasminogen activator and matrix metalloprotease 2

The peptide therapeutics market, valued at approximately 46 to 53 billion dollars and projected to reach 80 to 100 billion dollars within the next decade, is driving enormous investment in oral and sublingual delivery technologies

Additionally, vials offer an extent of flexibility during clinical experimentation, which allows for peptide concentrations and combinations to be customised depending on the objective of the investigation

Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation